For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Liver diseases
- Cancer
Companies Covered:
- Akero Therapeutics Inc.
- Bristol-Myers Squibb
- CymaBay Therapeutics Inc.
- Enanta Pharmaceuticals Inc.
- Galmed Pharmaceuticals Ltd.
- Gilead Sciences
- Intercept Pharmaceuticals Inc.
- Inventiva S.A.
- Madrigal Pharmaceuticals Inc.
- Metacrine
- NGM Biopharmaceuticals Inc.
- Novartis
- Pfizer
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Akero Therapeutics Inc.
- Bristol-Myers Squibb
- CymaBay Therapeutics Inc.
- Enanta Pharmaceuticals Inc.
- Galmed Pharmaceuticals Ltd.
- Gilead Sciences
- Intercept Pharmaceuticals Inc.
- Inventiva S.A.
- Madrigal Pharmaceuticals Inc.
- Metacrine
- NGM Biopharmaceuticals Inc.
- Novartis
- Pfizer
- Terns Pharmaceuticals Inc.
- Viking Therapeutics Inc.
- Sagimet Biosciences Inc.

